Results 21 to 30 of about 380,564 (307)

Thrombolysis in Acute Ischemic Stroke [PDF]

open access: yesThe Journal of the American Board of Family Medicine, 1998
The administration of rt-PA to patients with acute ischemic stroke can result in improved functional outcomes. The safe and effective use of rt-PA in routine medical practice requires that patients seek help early, have a well-defined onset of their symptoms, be carefully examined for contraindications to rt-PA, receive a CT scan and interpretation to ...
A, Luisi, A L, Hume
openaire   +2 more sources

QT interval prolongation in patients with acute ischemic stroke: a report in northwest China

open access: yesJournal of International Medical Research, 2019
Aims QT interval prolongation is common in patients with stroke and increases the risk of malignant arrhythmia and sudden death. Our aim was to analyze differences in the QT interval and electrocardiogram abnormalities between acute ischemic stroke ...
Jine Wu   +7 more
doaj   +1 more source

Acute Stroke Care in Mexico City: The Hospital Phase of a Stroke Surveillance Study

open access: yesBrain Sciences, 2022
Background: Acute stroke care has greatly improved in recent decades. However, the increasing stroke mortality in low-to-middle income countries suggests that progress has not been reached completely by these populations.
Emmanuel Aguilar-Salas   +17 more
doaj   +1 more source

Using Tenecteplase for Acute Ischemic Stroke: What Is the Hold Up? [PDF]

open access: yes, 2020
Alteplase is the only Food and Drug Administration-approved intravenous (IV) thrombolytic medication for acute ischemic stroke. However, multiple recent studies comparing tenecteplase and alteplase suggest that tenecteplase is at least as efficacious as ...
Ataya, Ramsey, Brea, Isabel, Zitek, Tony
core  

Arterial stiffness and ischemic stroke in subjects with and without metabolic syndrome. [PDF]

open access: yes, 2012
We conducted a study to evaluate arterial stiffness markers in subjects with acute ischemic stroke and metabolic syndrome and in relation to TOAST subtype of stroke. We enrolled 130 patients with acute ischemic stroke and metabolic syndrome, 127 patients
Arnao, V.   +7 more
core   +1 more source

Effect of hyperthermia on prognosis after acute ischemic stroke [PDF]

open access: yes, 2009
<p><b>Background and Purpose:</b> Experimental studies have shown that hyperthermia is a determinant of poor outcome after ischemic stroke.
Kamruzzaman, A.   +4 more
core   +1 more source

Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation [PDF]

open access: yes, 2010
<p><b>Background and Purpose:</b> Mechanisms of early neurologic deterioration after treatment with intravenous, recombinant, tissue-type plasminogen activator (IV rt-PA) include symptomatic intracerebral hemorrhage (SICH) and early ...
Awadh, M.   +5 more
core   +1 more source

Non-coding RNAs in acute ischemic stroke: from brain to periphery

open access: yesNeural Regeneration Research
Acute ischemic stroke is a clinical emergency and a condition with high morbidity, mortality, and disability. Accurate predictive, diagnostic, and prognostic biomarkers and effective therapeutic targets for acute ischemic stroke remain undetermined. With
Shuo Li   +9 more
doaj   +1 more source

Acute Ischemic Stroke in COVID-19: Putative Mechanisms, Clinical Characteristics, and Management

open access: yesNeurology Research International, 2020
The emergence and spread of the highly contagious novel coronavirus disease (COVID-19) have triggered the greatest public health challenge of the last century.
Ademola S. Ojo   +2 more
doaj   +1 more source

A Mechanistic Link to Peripheral Endothelial Dysfunction [PDF]

open access: yes, 2017
Background: Sleep‐disordered breathing (SDB) after acute ischemic stroke is frequent and may be linked to stroke‐induced autonomic imbalance. In the present study, the interaction between SDB and peripheral endothelial dysfunction (ED) was investigated ...
Anker, Stefan D.   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy